Your browser doesn't support javascript.
loading
Novel partial deletions, frameshift and missense mutations of CSF1R in patents with CSF1R-related leukoencephalopathy.
Ishiguro, Takanobu; Konno, Takuya; Hara, Norikazu; Zhu, Bin; Okada, Satoshi; Shibata, Mamoru; Saika, Reiko; Kitano, Takaya; Toko, Megumi; Nezu, Tomohisa; Hama, Yuka; Kawazoe, Tomoya; Takahashi-Iwata, Ikuko; Yabe, Ichiro; Sato, Kota; Takeda, Hayato; Toda, Shintaro; Nishimiya, Jin; Teduka, Toshiyuki; Nozaki, Hiroaki; Kasuga, Kensaku; Miyashita, Akinori; Onodera, Osamu; Ikeuchi, Takeshi.
Afiliação
  • Ishiguro T; Department of Neurology, Brain Research Institute, Niigata University, Niigata, Japan.
  • Konno T; Department of Neurology, Brain Research Institute, Niigata University, Niigata, Japan.
  • Hara N; Department of Molecular Genetics, Brain Research Institute, Niigata University, Niigata, Japan.
  • Zhu B; Department of Molecular Genetics, Brain Research Institute, Niigata University, Niigata, Japan.
  • Okada S; Department of Neurology, Ichikawa General Hospital, Tokyo Dental College, Ichikawa, Japan.
  • Shibata M; Department of Neurology, Ichikawa General Hospital, Tokyo Dental College, Ichikawa, Japan.
  • Saika R; Department of Neurology, Osaka Red Cross Hospital, Osaka, Japan.
  • Kitano T; Department of Neurology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Toko M; Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.
  • Nezu T; Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.
  • Hama Y; Department of Neurology, National Center Hospital, National Center of Neurology and Psychiatry, Kodaira, Japan.
  • Kawazoe T; Department of Neurology, Tokyo Metropolitan Neurological Hospital, Fuchu, Japan.
  • Takahashi-Iwata I; Department of Neurology, Hokkaido University School of Medicine, Sapporo, Japan.
  • Yabe I; Department of Neurology, Hokkaido University School of Medicine, Sapporo, Japan.
  • Sato K; Department of Neurology, Brain Attack Center Ota Memorial Hospital, Fukuyama, Japan.
  • Takeda H; Department of Neurology, University of Tsukuba, Tsukuba, Japan.
  • Toda S; Department of Neurology, Kyoto Katsura Hospital, Katsura, Japan.
  • Nishimiya J; Department of Neurology, Gyotoku General Hospital, Ichikawa, Japan.
  • Teduka T; Department of Neurology, Brain Research Institute, Niigata University, Niigata, Japan.
  • Nozaki H; Department of Neurology, Brain Research Institute, Niigata University, Niigata, Japan.
  • Kasuga K; Department of Molecular Genetics, Brain Research Institute, Niigata University, Niigata, Japan.
  • Miyashita A; Department of Molecular Genetics, Brain Research Institute, Niigata University, Niigata, Japan.
  • Onodera O; Department of Neurology, Brain Research Institute, Niigata University, Niigata, Japan.
  • Ikeuchi T; Department of Molecular Genetics, Brain Research Institute, Niigata University, Niigata, Japan.
Eur J Neurol ; 30(7): 1861-1870, 2023 07.
Article em En | MEDLINE | ID: mdl-36943150
BACKGROUND AND PURPOSE: Colony-stimulating factor 1 receptor (CSF1R)-related leukoencephalopathy is an adult-onset leukoencephalopathy caused by mutations in CSF1R. The present study aimed to explore the broader genetic spectrum of CSF1R-related leukoencephalopathy in association with clinical and imaging features. METHODS: Mutational analysis of CSF1R was performed for 100 consecutive patients with adult-onset leukoencephalopathy. Sequence and copy number variation (CNV) analyses of CSF1R were performed. The genomic ranges of the deletions were determined by long-read sequencing. Ligand-dependent autophosphorylation of CSF1R was examined in cells expressing the CSF1R mutants identified in this study. RESULTS: CSF1R mutations were identified in 15 patients, accounting for 15% of the adult-onset leukoencephalopathy cases. Seven novel and five previously reported CSF1R mutations were identified. The novel mutations, including three missense and one in-frame 3 bp deletion, were located in the tyrosine kinase domain (TKD) of CSF1R. Functional assays revealed that none of the novel mutations in the TKD showed autophosphorylation of CSF1R. Two partial deletions of CSF1R were identified that resulted in lack of the C-terminal region, including the distal TKD, in two patients. Various clinical features including cognitive impairment, psychiatric symptoms and gait disturbance were observed. Various degrees of the white matter lesions and corpus callosum abnormalities on magnetic resonance imaging and characteristic calcifications on computed tomography were observed as imaging features. CONCLUSIONS: Our results highlight the importance of examining the CNV of CSF1R even when Sanger or exome sequencing reveals no CSF1R mutations. Genetic examination of sequences and CNV analyses of CSF1R are recommended for an accurate diagnosis of CSF1R-related leukoencephalopathy.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Fator Estimulador de Colônias / Mutação de Sentido Incorreto / Leucoencefalopatias Tipo de estudo: Prognostic_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Fator Estimulador de Colônias / Mutação de Sentido Incorreto / Leucoencefalopatias Tipo de estudo: Prognostic_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article